Injectpower works closely with its partners, who have paved the way for a transformative energy storage product.
ENABLING THE FUTURE OF DIGITAL HEALTH
Injectpower develops energy storage technology and microbatteries for implantable medical devices. Its miniaturized solid state battery enables devices to operate as sensors or actuators that collect data continuously and autonomously for weeks without recharging. Our microbatteries, developed over 16 years with 40 patents, are manufactured using a validated semiconductor supply chain, offering high reliability. Over 1 million have been produced to date.
Philippe Andreucci, CEO & Co-founder (FR)
Andreucci has a strong background in transforming innovation in labs to real products. He has 20 years of R&D, product engineering, marketing & management in microelectronics, micro & nanosystems. He was previously co-founder and director of the CEA-CALTECH Alliance in nanosystems (France-USA). He is a skilled entrepreneur who has raised more than 30M Euros in funding), and has extensive business development experience in bringing in strategic customers. He was co-founder and CEO (7 years) of APIX Analytics (France) & a board member for numerous Deeptech start-ups.
Ariel Cao, co-founder (USA)
Cao brings a strong background in team building, organizational management, business development and technical expertise to Injectsense. With more than 25 years of experience in electronic device design and fabrication, product marketing/lifecycle management, and executive administration, his in-depth knowledge across multiple industry sectors has enabled him to secure more than $375 million dollars in contracts for cutting-edge semiconductor products, medical devices, sensors, and intellectual property.
Enrique Malaret, co-founder (USA)
Malret brings more twenty-eight years of medical product development and regulatory knowledge to Injectsense. With an exemplary record as engineering manager at Medtronic, and as co-founder and COO at 3 of his own companies, he has developed and launched 8 products and design enhancements and taken them through clinical trials to market release. His team management and leadership at Medtronic secured him a quality award for device yields over 99 percent, while his development expertise at his own company enabled him to increase revenue from $500K to $4M, resulting in the acquisition of the firm by Tronics Microsystems.